Matthew J. Tinguely

Matthew J. Tinguely

Hematology | Oncology
820 Fourth St. N.
Fargo, ND 58102

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 1 publications

Phase II study of dichloroacetate, an inhibitor of pyruvate dehydrogenase, in combination with chemoradiotherapy for unresected, locally advanced head and neck squamous cell carcinoma.

Phase II study of dichloroacetate, an inhibitor of pyruvate dehydrogenase, in combination with chemoradiotherapy for unresected, locally advanced head and neck squamous cell carcinoma.

Journal: Investigational new drugs
Published: December 07, 2021
Showing 1-1 of 1

Last Updated: 09/26/2026